Calendar
event
Ex dividend date
14 May 2025
event_available
Last Dividend Payment
15 May 2025
About Alcon AG
Ticker
info
ALC
Trading on
info
NYSE
ISIN
info
CH0432492467
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
David J. Endicott
Headquarters
info
Chemin de Blandonnet 8, Geneva, undefined, Switzerland, 1214
Employees
info
25,000
Website
info
alcon.com
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Metrics
BasicAdvanced
Market cap
info
$43B
P/E ratio
info
38.66
EPS
info
$2.25
Dividend Yield
info
0.38%
Beta
info
0.7
Forward P/E ratio
info
27.86
EBIDTA
info
$2.33B
Ex dividend date
info
2025-05-14
Price & volume
Market cap
info
$43B
Average daily volume
info
1.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.31
Dividend yield
info
0.38%
Forward dividend per share
info
$0.33
Forward dividend yield
info
0.38%
Payout ratio
info
12.26%
Valuation
P/E ratio
info
38.66
Forward P/E
info
27.86
PEG ratio
info
2.34
Trailing P/E
info
38.66
Price to sales
info
4.33
Price to book
info
1.96
Earnings
EPS
info
$2.25
EPS estimate (current quarter)
info
$0.77
EPS estimate (next quarter)
info
$0.78
EBITDA
info
$2.33B
Revenues (TTM)
info
$9.93B
Revenues per share (TTM)
info
$20.06
Technicals
Beta
info
0.7
52-week High
info
$100.74
52-week Low
info
$80.19
50-day moving average
info
$89.26
200-day moving average
info
$90.16
Short ratio
info
2.74
Short %
info
1.52%
Management effectiveness
ROE (TTM)
info
5.23%
ROA (TTM)
info
2.74%
Profit margin
info
11.28%
Gross profit margin
info
$5.52B
Operating margin
info
13.30%
Growth
Quarterly earnings growth (YoY)
info
40.00%
Quarterly revenue growth (YoY)
info
0.60%
Share stats
Outstanding Shares
info
495M
Float
info
495M
Insiders %
info
0.13%
Institutions %
info
68.26%
Analyst Insights & forecasts
info

78% Buy

22% Hold

0% Sell

Based on information from 27 analysts.

Average price target

info
$105.79
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.74
$0.73
1.37%
Q2 • 24Beat
$0.53
$0.74
-29.04%
Q3 • 24Missed
$0.72
$0.72
0.57%
Q4 • 24Beat
$0.73
$0.76
-4.27%
Q1 • 25Missed
-
$0.72
-100.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.5B
$284M
11.35%
Q4 • 24
$2.47B
$350M
14.15%
Q1 • 25
-1.16%
23.24%
24.68%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$30.3B
$8.79B
28.98%
Q4 • 24
$31B
$8.99B
28.99%
Q1 • 25
2.18%
2.22%
0.04%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$463M
-
$-7.7M
$313M
Q4 • 24
$384M
$-578M
$-96M
$384M
Q1 • 25
-17.05%
-
1,147.09%
22.61%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Alcon AG share?
Collapse

Alcon AG shares are currently traded for undefined per share.

How many shares does Alcon AG have?
Collapse

Alcon AG currently has 495M shares.

Does Alcon AG pay dividends?
Collapse

Yes, Alcon AG does pay dividends.

What is Alcon AG 52 week high?
Collapse

Alcon AG 52 week high is $100.74.

What is Alcon AG 52 week low?
Collapse

Alcon AG 52 week low is $80.19.

What is the 200-day moving average of Alcon AG?
Collapse

Alcon AG 200-day moving average is $90.16.

Who is Alcon AG CEO?
Collapse

The CEO of Alcon AG is David J. Endicott.

How many employees Alcon AG has?
Collapse

Alcon AG has 25,000 employees.

What is the market cap of Alcon AG?
Collapse

The market cap of Alcon AG is $43B.

What is the P/E of Alcon AG?
Collapse

The current P/E of Alcon AG is 38.66.

What is the EPS of Alcon AG?
Collapse

The EPS of Alcon AG is $2.25.

What is the PEG Ratio of Alcon AG?
Collapse

The PEG Ratio of Alcon AG is 2.34.

What do analysts say about Alcon AG?
Collapse

According to the analysts Alcon AG is considered a buy.